Logo

People in the News: New Board Member, CEO at Applied Proteomics

Feb 10, 2012
Premium

Applied Proteomics announced this week that it has appointed Peter Klemm as CEO and James Blair to its board of directors.

Klemm is currently chairman of Pathwork Diagnostics and was previously the CEO and president of Predictive Biosciences. He was also CEO of GeneOhm Sciences, which was acquired by Becton Dickinson.

Blair is a founding partner at Domain Associates, which recently participated in API's $22.5 million Series B funding round (See story, this issue).

Filed under

Proteomics & Protein Research
proteomics
Pathwork Diagnostics
Becton Dickinson
Predictive Biosciences
Applied Proteomics
Domain Associates
Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.